Led Scienta Lab's EUR 4M round for its immunology foundation model.
DEC 8, 2023
Paris-based deeptech company developing EVA, an AI foundation model purpose-built for translational prediction in immunology and immune-mediated diseases
Paris-based deeptech company developing EVA, an AI foundation model purpose-built for translational prediction in immunology and immune-mediated diseases. It integrates multimodal biological data to predict patient-level drug efficacy and outcomes, helping pharmaceutical and biotech teams bridge the preclinical-to-clinical gap and inform drug development decisions, including target selection and patient stratification.